Phase II trial design considerations for small-cell lung cancer.
Moore
T D
TD
Clinical Investigations Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Korn
E L
EL
D000367:Age Factors; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods*; D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012107:Research Design